HLN (Haleon) Tax Expense: $637 Mil (TTM As of Dec. 2025)


HLN Haleon PLC HLN
70 GF Score
Price $9.72
GF Value $9.81
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Haleon Tax Expense?

Haleon HLN -1.02% 70 Tax Expense is $637 Mil as of Dec. 2025. GuruFocus rates HLN with a GF Score™ of 70/100 and a GF Value™ of $9.81 (Fairly Valued). The stock has 3 warning signs investors should review.

Haleon's tax expense for the months ended in Dec. 2025 was $281 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2025 was $637 Mil.


Haleon  (NYSE:HLN) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Haleon Tax Expense Related Terms


Haleon Tax Expense Historical Data

* Premium members only.

The historical data trend for Haleon's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleon Tax Expense Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Expense
Get a 7-Day Free Trial 261.97 607.80 654.43 549.94 631.86

Haleon Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 363.29 307.89 244.00 355.50 281.12
HLN
70GF Score
Haleon PLC HLN
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haleon Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $637 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of $637 Mil mean?
Haleon (HLN) has a Tax Expense of $637 Mil as of Dec. 2025. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Haleon and its competitors.
Is Haleon's Tax Expense too high?
Haleon's current Tax Expense is $637 Mil. Overall, Haleon has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Haleon's Tax Expense compare to ZTS and UTHR?
Haleon's Tax Expense of $637 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Drug Manufacturers company?
A good Tax Expense depends on the Drug Manufacturers industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Haleon and its competitors. Haleon's current Tax Expense is $637 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleon stock overvalued right now?
Based on GuruFocus' analysis, Haleon (HLN) is currently considered Fairly Valued. The stock's GF Value™ is $9.81, compared to a current price of $9.72 — trading 0.9% below its estimated fair value. The current Tax Expense is $637 Mil. Haleon's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Haleon (HLN), the current Tax Expense is $637 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haleon (HLN) Overvalued in 2026?

Based on GuruFocus' analysis, Haleon stock appears to be undervalued. The current stock price of $9.72 is trading 0.9% below its estimated GF Value™ of $9.81. GuruFocus considers Haleon to be Fairly Valued.

Key valuation signals for HLN:

  • Tax Expense: $637 Mil
  • GF Value™: $9.81 vs. price of $9.72 (0.9% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the HLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Haleon Business Description

Address The Heights, Building 5, First Floor, Weybridge, Surrey, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
70GF Score

Get the complete analysis for HLN

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.72
Price
$9.81
GF Value